Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Mar 15, 2016; 8(3): 258-270
Published online Mar 15, 2016. doi: 10.4251/wjgo.v8.i3.258
Published online Mar 15, 2016. doi: 10.4251/wjgo.v8.i3.258
Table 1 Some venous thromboembolic event risk factors in cancer patients
| Cancer-related | Patient-related | Treatment-related |
| Reduced mobility | ||
| Primary cancer (e.g., pancreatic cancer > colo-rectal cancer) | Age | Operation |
| Stage (IV > III) | History of VTE | Chemotherapy |
| Histology (e.g., adeno- > squamous cell-carcinoma) | Infection/fever | Central line/ port-catheter |
| Grade (3 > 2) | Parenteral nutrition | |
| Thrombocytosis | Radiation therapy | |
| Leukocytosis | ||
| Acute phase (elevated CRP) | ||
| Elevated D-dimer |
- Citation: Riess H, Habbel P, Jühling A, Sinn M, Pelzer U. Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol 2016; 8(3): 258-270
- URL: https://www.wjgnet.com/1948-5204/full/v8/i3/258.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i3.258